ZA200901680B - Recombinant human interferon-like proteins - Google Patents

Recombinant human interferon-like proteins

Info

Publication number: ZA200901680B
Authority: ZA; South Africa
Prior art keywords: proteins; recombinant human; human interferon; interferon; recombinant
Prior art date: 2007-06-18

Application number

ZA200901680A

Other languages

English (en)

Inventor

Haitao Wang

Chunsheng Mao

Jizhi Li

Ling Wang

Yong Du

Lkongbin Liu

Jing Xu

Rui Zhang

Original Assignee

Novagen Holding Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-18

Filing date

2009-03-10

Publication date

2010-03-31

2009-03-10 Application filed by Novagen Holding Corp filed Critical Novagen Holding Corp

2010-03-31 Publication of ZA200901680B publication Critical patent/ZA200901680B/xx

Links

102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Toxicology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Virology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Physics & Mathematics (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Reproductive Health (AREA)

ZA200901680A 2007-06-18 2009-03-10 Recombinant human interferon-like proteins ZA200901680B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11/764,786 US7625555B2 (en)	2007-06-18	2007-06-18	Recombinant human interferon-like proteins

Publications (1)

Publication Number	Publication Date
ZA200901680B true ZA200901680B (en)	2010-03-31

Family

ID=40132903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200901680A ZA200901680B (en)	2007-06-18	2009-03-10	Recombinant human interferon-like proteins

Country Status (20)

Country	Link
US (8)	US7625555B2 (fr)
EP (3)	EP2465935B1 (fr)
JP (3)	JP5439189B2 (fr)
KR (2)	KR20130027043A (fr)
CN (3)	CN103483443A (fr)
AU (1)	AU2007355415B2 (fr)
BR (1)	BRPI0716948B1 (fr)
CA (1)	CA2692358C (fr)
DK (2)	DK2465935T3 (fr)
ES (2)	ES2524251T3 (fr)
IL (1)	IL196673A (fr)
MX (1)	MX2009001366A (fr)
MY (1)	MY167485A (fr)
NZ (1)	NZ574306A (fr)
PL (2)	PL2465935T3 (fr)
PT (2)	PT2465935T (fr)
RU (1)	RU2469091C2 (fr)
TW (1)	TWI375716B (fr)
WO (1)	WO2008154719A1 (fr)
ZA (1)	ZA200901680B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7625555B2 (en)	2007-06-18	2009-12-01	Novagen Holding Corporation	Recombinant human interferon-like proteins
MX2012010148A (es)	2010-03-04	2013-01-22	Pfenex Inc	Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion.
AU2014322046B2 (en) *	2013-09-20	2021-02-04	Daiichi Sankyo Company, Limited	Complex containing oligonucleotide having immunopotentiating activity and use thereof
LT6164B (lt)	2013-10-15	2015-06-25	Uab Biotechnologinės Farmacijos Centras "Biotechpharma"	Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas
US10519209B2 (en) *	2014-07-14	2019-12-31	Gennova Biopharmaceuticals Limited	Process for purification of rHu-GCSF
WO2018041973A1 (fr) *	2016-09-01	2018-03-08	Proqr Therapeutics Ii B.V.	Oligonucléotides d'édition d'arn simple brin chimiquement modifiés
WO2018101151A1 (fr) *	2016-12-02	2018-06-07	興人ライフサイエンス株式会社	Condiment de levure contenant du ribose
US10780931B2 (en) *	2018-05-21	2020-09-22	Ronald Siwicki	Kickstand assembly
CN109627343A (zh) *	2018-12-27	2019-04-16	北京美福源生物医药科技有限公司	长效细胞因子基因衍生物融合蛋白
CN113289006A (zh) *	2020-02-24	2021-08-24	杰华生物技术(青岛)有限公司	一种重组细胞因子基因衍生蛋白或其片段的用途

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US369922A (en)		1887-09-13		Jacket for steam-cylinders
US2004200A (en) *	1931-10-02	1935-06-11	Union Switch & Signal Co	Lamp socket adapter
US3699222A (en)	1958-03-11	1972-10-17	Nat Res Dev	Production of viral interfering substances
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4640835A (en)	1981-10-30	1987-02-03	Nippon Chemiphar Company, Ltd.	Plasminogen activator derivatives
GB2148299B (en)	1983-09-01	1988-01-06	Hybritech Inc	Antibody compositions of therapeutic agents having an extended serum half-life
US4496689A (en)	1983-12-27	1985-01-29	Miles Laboratories, Inc.	Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
GB8412564D0 (en)	1984-05-17	1984-06-20	Searle & Co	Structure and properties
ATE78262T1 (de)	1985-06-11	1992-08-15	Ciba Geigy Ag	Hybrid-interferone.
US4791192A (en)	1986-06-26	1988-12-13	Takeda Chemical Industries, Ltd.	Chemically modified protein with polyethyleneglycol
GB8803365D0 (en)	1988-02-13	1988-03-16	Ciba Geigy Ag	Antiviral combination
US5705363A (en)	1989-03-02	1998-01-06	The Women's Research Institute	Recombinant production of human interferon τ polypeptides and nucleic acids
US5681811A (en)	1993-05-10	1997-10-28	Protein Delivery, Inc.	Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
HUT75533A (en)	1993-11-10	1997-05-28	Schering Corp	Improved interferon polymer conjugates
US6335160B1 (en)	1995-02-17	2002-01-01	Maxygen, Inc.	Methods and compositions for polypeptide engineering
US5605793A (en)	1994-02-17	1997-02-25	Affymax Technologies N.V.	Methods for in vitro recombination
US5738846A (en)	1994-11-10	1998-04-14	Enzon, Inc.	Interferon polymer conjugates and process for preparing the same
FR2741892B1 (fr)	1995-12-04	1998-02-13	Pasteur Merieux Serums Vacc	Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
US5723125A (en)	1995-12-28	1998-03-03	Tanox Biosystems, Inc.	Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
CA2311681A1 (fr)	1997-12-08	1999-06-17	Genentech, Inc.	Interferon-epsilon humain: interferon de type 1
US6685933B1 (en)	1998-07-28	2004-02-03	The United States Of America As Represented By The Department Of Health And Human Services	Interferon α hybrids
US6514729B1 (en)	1999-05-12	2003-02-04	Xencor, Inc.	Recombinant interferon-beta muteins
US7431921B2 (en)	1999-08-27	2008-10-07	Maxygen Aps	Interferon beta-like molecules
KR20020034181A (ko)	1999-08-27	2002-05-08	맥시겐 에이피에스	새로운 인터페론 베타-유사 분자
US6531122B1 (en)	1999-08-27	2003-03-11	Maxygen Aps	Interferon-β variants and conjugates
US20040002474A1 (en)	1999-10-07	2004-01-01	Maxygen Inc.	IFN-alpha homologues
AU8001300A (en)	1999-10-07	2001-05-10	Maxygen, Inc.	Ifn-alpha homologues
JP2003513681A (ja)	1999-11-12	2003-04-15	マキシゲン・ホールディングス・リミテッド	インターフェロンガンマ・コンジュゲート
IT1317835B1 (it) *	2000-02-15	2003-07-15	San Raffaele Centro Fond	Citochine modificate per uso nella terapia del cancro.
AU2001244711A1 (en)	2000-03-31	2001-10-08	Mochida Pharmaceutical Co., Ltd.	Tlr/cd14 binding inhibitor
WO2002036628A2 (fr)	2000-11-02	2002-05-10	Maxygen Aps	Nouveaux polypeptides $g(b) interferon multimeres
EP1355939A2 (fr)	2000-11-03	2003-10-29	Pestka Biomedical Laboratories, Inc.	Interferons, utilisations et compositions associees
EP1366075B1 (fr)	2001-02-27	2009-05-27	Maxygen Aps	Nouvelles molecules de type interferon beta
US6958388B2 (en)	2001-04-06	2005-10-25	Maxygen, Aps	Interferon gamma polypeptide variants
US7038015B2 (en)	2001-04-06	2006-05-02	Maxygen Holdings, Ltd.	Interferon gamma polypeptide variants
PL366705A1 (en)	2001-04-06	2005-02-07	Maxygen Holdings Ltd.	Interferon gamma polypeptide variants
FR2825102B1 (fr)	2001-05-23	2003-08-29	Genodyssee	Nouveaux polynucleotides et polypeptides de l'interferon alpha 14
WO2003002152A2 (fr)	2001-06-29	2003-01-09	Maxygen Aps	Formulations d'interféron
CN1431018A (zh)	2002-01-10	2003-07-23	北京东康龙病毒生物技术工程研究中心	抗HSV感染和镇痛的人甲硫氨酸脑啡肽干扰素α－m融合蛋白制剂
WO2003075944A2 (fr)	2002-03-12	2003-09-18	Maxygen Aps	Molecules de type interferon beta destinees au traitement des accidents vasculaires cerebraux
WO2004005341A2 (fr)	2002-07-03	2004-01-15	Maxygen Holdings Ltd.	Variants polypeptidiques a interferon gamma pleine longueur
WO2004020468A2 (fr)	2002-08-28	2004-03-11	Maxygen Aps	Molecules d'interferon de type $g(b) pour le traitement du cancer
WO2004022593A2 (fr)	2002-09-09	2004-03-18	Nautilus Biotech	Evolution rationnelle de cytokines pour une plus grande stabilite, les cytokines et molecules d'acide nucleique codant
US7314613B2 (en)	2002-11-18	2008-01-01	Maxygen, Inc.	Interferon-alpha polypeptides and conjugates
NZ540043A (en)	2002-11-18	2007-11-30	Maxygen Inc	Isolated or recombinant Interferon-alpha polypeptides and conjugates
JP2006526022A (ja) *	2003-05-23	2006-11-16	ペスカバイオメディカルラボラトリーズ，インク．	重症急性呼吸器症候群及び他のウィルス感染の治療のためのインターフェロンの使用
WO2005113592A2 (fr)	2004-05-19	2005-12-01	Maxygen, Inc.	Polypeptides et conjugues interferon-alpha
MX2007001589A (es) *	2004-08-09	2007-08-02	Alios Biopharma Inc	Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
US20060051859A1 (en)	2004-09-09	2006-03-09	Yan Fu	Long acting human interferon analogs
CA2607651A1 (fr) *	2005-05-18	2007-04-19	Maxygen, Inc.	Polypeptides d'interferon-alpha mis au point genetiquement
US7625555B2 (en)	2007-06-18	2009-12-01	Novagen Holding Corporation	Recombinant human interferon-like proteins

2007
- 2007-06-18 US US11/764,786 patent/US7625555B2/en active Active
- 2007-06-22 CN CN201310296591.7A patent/CN103483443A/zh active Pending
- 2007-06-22 MY MYPI20080140A patent/MY167485A/en unknown
- 2007-06-22 WO PCT/CA2007/001123 patent/WO2008154719A1/fr not_active Ceased
- 2007-06-22 BR BRPI0716948-5A patent/BRPI0716948B1/pt active IP Right Grant
- 2007-06-22 RU RU2009104749/10A patent/RU2469091C2/ru active
- 2007-06-22 CA CA2692358A patent/CA2692358C/fr active Active
- 2007-06-22 DK DK12159128.3T patent/DK2465935T3/en active
- 2007-06-22 EP EP12159128.3A patent/EP2465935B1/fr active Active
- 2007-06-22 KR KR1020137002067A patent/KR20130027043A/ko not_active Ceased
- 2007-06-22 DK DK07720038.4T patent/DK2078082T3/en active
- 2007-06-22 ES ES07720038.4T patent/ES2524251T3/es active Active
- 2007-06-22 NZ NZ574306A patent/NZ574306A/en unknown
- 2007-06-22 US US12/665,682 patent/US8425895B2/en active Active
- 2007-06-22 MX MX2009001366A patent/MX2009001366A/es active IP Right Grant
- 2007-06-22 EP EP16170023.2A patent/EP3133161A1/fr not_active Withdrawn
- 2007-06-22 KR KR1020097003909A patent/KR101384307B1/ko active Active
- 2007-06-22 PT PT121591283T patent/PT2465935T/pt unknown
- 2007-06-22 AU AU2007355415A patent/AU2007355415B2/en active Active
- 2007-06-22 ES ES12159128.3T patent/ES2586398T3/es active Active
- 2007-06-22 CN CN200780000441XA patent/CN101432428B/zh active Active
- 2007-06-22 PL PL12159128T patent/PL2465935T3/pl unknown
- 2007-06-22 PL PL07720038T patent/PL2078082T3/pl unknown
- 2007-06-22 CN CN2011101550823A patent/CN102250918A/zh active Pending
- 2007-06-22 PT PT77200384T patent/PT2078082E/pt unknown
- 2007-06-22 JP JP2009545766A patent/JP5439189B2/ja active Active
- 2007-06-22 EP EP07720038.4A patent/EP2078082B1/fr active Active
- 2007-12-07 TW TW096146800A patent/TWI375716B/zh active
2009
- 2009-01-22 IL IL196673A patent/IL196673A/en active IP Right Grant
- 2009-03-10 ZA ZA200901680A patent/ZA200901680B/xx unknown
- 2009-09-08 US US12/555,762 patent/US7868151B2/en active Active
- 2009-09-08 US US12/555,759 patent/US7867482B2/en active Active
2013
- 2013-03-15 US US13/841,679 patent/US9234022B2/en active Active
- 2013-08-23 JP JP2013173596A patent/JP6099095B2/ja active Active
2016
- 2016-01-11 US US14/992,591 patent/US9982028B2/en active Active
- 2016-03-04 JP JP2016042061A patent/JP2016117753A/ja active Pending
2018
- 2018-04-30 US US15/967,125 patent/US10538565B2/en active Active
2019
- 2019-12-04 US US16/703,760 patent/US20200369741A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20190077843A1 (en)	2019-03-14
US7868151B2 (en)	2011-01-11
KR101384307B1 (ko)	2014-05-21
US7625555B2 (en)	2009-12-01
JP2016117753A (ja)	2016-06-30
US20080312148A1 (en)	2008-12-18
EP2078082A4 (fr)	2009-12-16
EP2465935A2 (fr)	2012-06-20
US20130189226A1 (en)	2013-07-25
JP5439189B2 (ja)	2014-03-12
US9234022B2 (en)	2016-01-12
IL196673A0 (en)	2011-08-01
CN101432428B (zh)	2013-06-19
CN103483443A (zh)	2014-01-01
JP6099095B2 (ja)	2017-03-22
JP2010515466A (ja)	2010-05-13
PT2078082E (pt)	2014-11-27
CN102250918A (zh)	2011-11-23
EP2078082A1 (fr)	2009-07-15
US20100129904A1 (en)	2010-05-27
TWI375716B (en)	2012-11-01
US10538565B2 (en)	2020-01-21
US20200369741A1 (en)	2020-11-26
WO2008154719A1 (fr)	2008-12-24
RU2469091C2 (ru)	2012-12-10
US9982028B2 (en)	2018-05-29
MX2009001366A (es)	2009-04-17
TW200900504A (en)	2009-01-01
US20100099612A1 (en)	2010-04-22
US20100303759A1 (en)	2010-12-02
EP2078082B1 (fr)	2014-08-20
HK1171048A1 (en)	2013-03-15
ES2586398T3 (es)	2016-10-14
PT2465935T (pt)	2016-08-05
CN101432428A (zh)	2009-05-13
NZ574306A (en)	2012-07-27
EP2465935A3 (fr)	2012-08-15
AU2007355415B2 (en)	2012-07-26
EP2465935B1 (fr)	2016-05-18
HK1129128A1 (zh)	2009-11-20
JP2014036657A (ja)	2014-02-27
PL2078082T3 (pl)	2015-02-27
RU2009104749A (ru)	2010-11-20
US20170015723A1 (en)	2017-01-19
IL196673A (en)	2015-08-31
CA2692358A1 (fr)	2008-12-24
DK2078082T3 (en)	2014-12-01
PL2465935T3 (pl)	2017-08-31
MY167485A (en)	2018-08-30
EP3133161A1 (fr)	2017-02-22
BRPI0716948B1 (pt)	2022-04-05
ES2524251T3 (es)	2014-12-04
US7867482B2 (en)	2011-01-11
US8425895B2 (en)	2013-04-23
KR20130027043A (ko)	2013-03-14
CA2692358C (fr)	2012-11-20
KR20100033468A (ko)	2010-03-30
AU2007355415A1 (en)	2008-12-24
DK2465935T3 (en)	2016-08-22
BRPI0716948A2 (pt)	2013-02-19

Publication	Publication Date	Title
IL196673A0 (en)	2011-08-01	Recombinant human interferon-like proteins
PL3118220T3 (pl)	2020-02-28	Białko
IL203221A (en)	2015-03-31	Bioactive peptides and antibodies
GB0611116D0 (en)	2006-07-19	Proteins
GB0719231D0 (en)	2007-11-14	Protein
GB0423974D0 (en)	2004-12-01	Proteins
GB0601976D0 (en)	2006-03-15	Proteins
GB0725201D0 (en)	2008-01-30	Peptide fusion proteins
GB0620735D0 (en)	2006-11-29	Proteins
IL206334A0 (en)	2010-12-30	Sarp-i fusion proteins and their use
GB0724832D0 (en)	2008-01-30	Proteins and nucleic acids
GB0612623D0 (en)	2006-08-02	Proteins
GB0720563D0 (en)	2007-11-28	Protein
GB0612443D0 (en)	2006-08-02	Protein
GB0700759D0 (en)	2007-02-21	Novel fusion protein
GB0614682D0 (en)	2006-08-30	Proteins
GB0620304D0 (en)	2006-11-22	Protein
GB0511861D0 (en)	2005-07-20	Proteins
GB0422110D0 (en)	2004-11-03	Recombinant proteins
GB0423002D0 (en)	2004-11-17	Proteins
GB0713302D0 (en)	2007-08-22	Protein
IL206541A0 (en)	2010-12-30	Novel protein
GB0922155D0 (en)	2010-02-03	Interferon 8 fusion proteins
GB0616969D0 (en)	2006-10-04	Protein
GB0616971D0 (en)	2006-10-04	Protein